Article
The evolution of medulloblastoma therapy to personalized medicine
2017-04-13
Abstract excerpt
Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3f4ceebc-1660-5166-bb57-97e0c95711f8
- DOI
- 10.12688/f1000research.10859.1
